Physician profile
Maher Farah
NPI 1558442194
$630.13
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.87 · 2020: $118 · 2021: $207 · 2022: $124 · 2023: $70.00 · 2024: $16.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $86.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $86.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $195.56 | 2020-2023 | Xarelto |
| Pfizer INC. | $87.40 | 2019-2021 | |
| Chiesi USA, INC. | $78.90 | 2020 | |
| Abbvie INC. | $72.04 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $50.19 | 2022-2023 | Andexxa |
| Portola Pharmaceuticals, LLC | $48.68 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $25.42 | 2020-2021 | |
| Bioxcel Therapeutics, INC. | $23.31 | 2023 | Igalmi |
| Purdue Pharma L.P. | $16.86 | 2024 | Nalmefene Hydrochloride |
| Viiv Healthcare Company | $15.96 | 2019 | |
| Rare Disease Therapeutics, INC. | $15.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maher Farah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.